MedPath

Safety and acceptance of a herbal formulation Link LivecareTM (LLC) proposed to be used for fatty liver disease in healthy human volunteers-A single center open label Phase 1 clinical trial.

Phase 1
Conditions
iver disease
Registration Number
SLCTR/2021/030
Lead Sponsor
ink Natural Products (Pvt) Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow up continuing
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. The volunteers provides written informed consent before starting the study.
2. Volunteers who are in the age group 18 years to 60 years, healthy as defined by history, examination and systolic and diastolic blood pressure, and those who have normal baseline investigations, those who have normal liver function (serum bilirubin, AST, ALT, ALP, GGT, Serum albumin, FBS, coagulation tests (PT/INR)), renal function (urine full report, serum creatinine), hematological parameters (FBC, ESR), ultrasound scan of liver and liver fibro scan will be recruited to the study.
3. Both male and unmarried female volunteers will be recruited to the study.
Any female volunteer planning to get married during the 4 months after recruitment to the study will excluded from the study.

Exclusion Criteria

1. Volunteers with a history of chronic illness such as diabetes mellitus, hypertension, cardiovascular diseases, chronic liver and kidney disease, and any other disease that warrants long term medication (e.g., autoimmune disease).
2. Volunteers who have abnormal baseline investigations by history, examination, systolic and diastolic blood pressure, and those who have abnormal liver function (serum bilirubin, AST, ALT, ALP, GGT, serum albumin, FBS, coagulation tests (PT/INR)), renal function (Urine full report, Serum creatinine), hematological parameters (FBC, ESR), ultrasound scan of liver and liver fibro scan would be excluded from the trial.
3. Volunteers on any medicines, including nutritional, Ayurveda/ herbal supplements.
4. Married women volunteers and any women planning to get married during the 4 months after recruitment to the study.
5. Allergies or allergic reactions to any of the ingredients of LLC.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath